Abstract

COLORECTAL CANCER AND NOVELTY IN THE TREATMENT

*Mohit Das, Dr. Biswajit Das and Dr. Junmoni Kalita

Abstract

Colorectal cancer (CRC), it is the main source of demise in gastrointestinal cancer, additional major source of passing away associated to cancer and worldwide third furthermost mutual disease in both men and women. The hazard of colorectal cancer may develop due to the immoral alimentary behaviours, smoking, colonic provocative disease, polyps, heredities factors and aging. Inflammation may also associate with the developing cancer which may lead to the severity of the disease, signifying that removing inflammation can epitomize an effective approach for cancer deterrence and therapy. Due to the anti-inflammatory possessions, the nonsteroidal antiinflammatory drugs (NSAIDs) have been examined for its anticancer belongings in several revisions. This is for the reason that chronic inflammation for a while related to carcinogenesis. By and of itself, anti-inflammatory drugs are supposed to perform a character in cancer prevention and therapy. Since, monotherapy is usually not a satisfactory treatment of cancer, the collective practice of anti-inflammatory agents and conformist cancer therapy is correspondingly a crucial fact in discussion. This article explores the idea how colorectal cancer start and spread, what are its medication, what are the novelties in treatment and current status of anti-inflammatory agents in cancer treatment.

Keywords: Anti-inflammatory agents, Colorectal cancer, Novelties in treatment, Targeting inflammation.